s6y

Medicinal Chemicals & Botanical Products

42 listed companies the SEC classes under this industry (code 2833), in order of revenue.

40 of them have annual figures on record. The 36 reporting in US dollars had revenue of $7.02B between them in their latest fiscal years.

Company Fiscal year to
Curaleaf Holdings, Inc. Dec 2025 $1.27B−$231.1M$2.85B
Trulieve Cannabis Corp. Dec 2025 $1.18B−$122.2M$2.70B
Usana Health Sciences Inc Jan 2026 $925.3M$10.8M$742.9M
Tilray Brands, Inc. May 2026 $915.5M−$121.4M$2.33B
Cresco Labs Inc. Dec 2025 $655.8M−$135.4M$1.20B
Ascend Wellness Holdings, Inc. Dec 2025 $500.6M−$118.2M$907.9M
Jushi Holdings Inc. Dec 2025 $262.9M−$68.6M$422.3M
biote Corp. Dec 2025 $192.2M$27.0M$107.6M
Glass House Brands Inc. Dec 2025 $182.0M−$29.7M$318.6M
Marimed Inc. Dec 2025 $159.8M−$14.5M$202.6M
Cronos Group Inc. Dec 2025 $146.6M−$9.45M$1.20B
Natural Alternatives International Inc Jun 2026 $142.5M−$20.7M$126.4M
Niagen Bioscience, Inc. Dec 2025 $129.4M$17.4M$106.4M
Mannatech Inc Dec 2025 $108.0M−$15.2M$30.0M
Fitlife Brands, Inc. Dec 2025 $81.5M$6.33M$106.3M
Leef Brands Inc. Dec 2025 $34.8M−$17.6M$36.4M
C21 Investments Inc. Mar 2026 $32.6M−$3.24M$54.4M
Cyanotech Corp Mar 2025 $24.2M−$3.20M$23.5M
Charlie's Holdings, Inc. Dec 2025 $20.9M$4.50M$11.6M
Bon Natural Life Ltd Sep 2025 $18.7M−$1.99M$85.2M
MediWound Ltd. Dec 2025 $17.0M−$23.9M$86.3M
Functional Brands Inc. Dec 2025 $6.61M$758.5K$9.11M
Healthy Extracts Inc. Dec 2025 $4.51M−$881.1K$27.8M
Target Group Inc. Dec 2025 $3.88M−$1.36M$6.18M
Panacea Life Sciences Holdings, Inc. Dec 2023 $2.38M−$8.02M$18.0M
TFA Therapeutics, Inc. Dec 2025 $1.25M−$154.8K$4.66M
Adia Med, Inc. Dec 2025 $700.5K−$395.5K$594.8K
China Foods Holdings Ltd. Dec 2025 $327.9K−$398.7K$212.9K
Nutra Pharma Corp Dec 2025 $257.6K−$2.05M$584.6K
Neutra Corp. Jan 2023 $68.0K−$561.4K$75.2K
Aibotics Therapies, Inc. Dec 2025 $2.18K−$2.22M$874.7K
Definium Therapeutics, Inc. Dec 2025 –−$183.8M$440.1M
Regencell Bioscience Holdings Ltd Jun 2026 –−$11.7M$14.7M
SNDL Inc. Dec 2025 C$946.4M−C$15.8MC$1.34B
Aurora Cannabis Inc Mar 2025 –C$1.59MC$852.7M
Canopy Growth Corp Mar 2026 C$284.6M−C$262.9MC$1.12B
Raphael Pharmaceutical Inc. Dec 2025 –−$1.28M$53.0K
IM Cannabis Corp. Dec 2025 C$54.7M−C$11.3MC$31.7M
Cannaisseur Group Inc. Dec 2025 –−$1.77M$140
Glucose Health, Inc. Dec 2016 –−$410.4K$33.1K
CBD Life Sciences Inc.
Devonian Health Group Inc.

Each company's latest fiscal year, as its annual report to the SEC gave the figures; the year links to that report. Amounts in other currencies are not converted, and sort after those in dollars.